Supernus Pharmaceuticals (SUPN) Stock Insights

SUPN price $41.08 +0.12 +0.29%

Ticker
SUPN
Price
$41.08
Change
+0.12 +0.29%
Market cap ?
$2.39B
P/E ?
-21.18
Forward P/E ?
17.22
Dividend yield ?
0.00%
Beta ?
0.55
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Financials

2016201720182019202020212022202320242025
215003000302238000408897000392755000520397000579775000667238000607521000661817000718952000

Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for central nervous system (CNS) disorders within the United States. Its portfolio of marketed products includes Trokendi XR, an extended-release topiramate formulation prescribed for both epilepsy management and migraine prevention. Another key product is Oxtellar XR, an extended-release oxcarbazepine designed…

Fair value

SUPN fair value $91.73. Price $41.08. Price is 55% below fair value.

Below fair value, and cheaper than usual. A larger discount than on more than 99% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Average free cash flow, last three years 109.25M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 58.22M. Net debt -87.47M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare SUPN

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-10-29—0.49—217.56M
2026-08-030.540.42219.06M205.31M
2026-05-050.590.28207.71M192.92M
2026-02-240.920.28211.57M195.16M
2025-11-041.010.82192.10M194.73M
2025-08-050.910.47165.45M168.23M
2025-05-060.420.38149.82M147.94M
2025-02-250.750.46174.16M155.25M
2024-11-041.060.39175.69M154.51M
2024-08-060.360.37168.32M148.83M
2024-05-080.260.38143.64M145.83M
2024-02-270.020.41164.31M155.03M
2023-11-08-0.290.13153.88M155.27M
2023-08-08-0.020.23135.56M143.66M
2023-05-090.290.17153.76M139.02M
2023-02-280.430.68167.33M180.33M
2022-11-080.030.36177.35M172.48M
2022-08-040.140.29170.05M164.13M
2022-05-090.430.26152.51M153.91M
2022-02-280.040.24159.05M148.38M
2021-11-030.400.23148.46M118.11M
2021-08-040.430.20141.33M134.87M
2021-05-050.110.24130.93M129.42M
2021-02-250.570.52143.56M146.19M
2020-11-030.740.30155.13M24.39M
2020-08-180.650.42126.73M81.89M
2020-05-050.400.2894.98M66.48M
2020-02-250.620.60100.45M97.21M
2019-11-050.540.60102.14M113.49M
2019-08-060.610.58104.69M99.55M
2019-05-070.340.4785.47M118.16M
2019-02-260.480.27115.93M95.65M
2018-11-060.520.41103.00M81.21M
2018-08-070.570.4399.54M75.09M
2018-05-080.490.3390.43M60.90M
2018-02-270.440.2688.44M54.27M
2017-11-060.290.2780.40M74.85M
2017-08-020.320.2475.83M56.87M
2017-05-090.190.2257.58M66.67M
2017-02-280.260.2562.37M59.97M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-12Khattar Jack A.Buy29.85K——
2026-08-12Khattar Jack A.Sell12.64K$46.57588.74K
2026-08-12Khattar Jack A.Sell29.85K——
2026-08-12Rubin JonathanBuy750——
2026-08-12Rubin JonathanSell363$46.5716.90K
2026-08-12Rubin JonathanSell750——
2026-08-12Bhatt Padmanabh P.Buy2.50K——
2026-08-12Bhatt Padmanabh P.Sell1.16K$46.5753.93K
2026-08-12Bhatt Padmanabh P.Sell2.50K——
2026-08-12Mottola FrankBuy1.65K——
2026-08-12Mottola FrankSell797$46.5737.12K
2026-08-12Mottola FrankSell1.65K——
2026-08-12DEC TIMOTHY CBuy1.25K——
2026-08-12DEC TIMOTHY CSell604$46.5728.13K
2026-08-12DEC TIMOTHY CSell1.25K——
2026-07-29Khattar Jack A.Buy29.85K——
2026-07-29DEC TIMOTHY CBuy1.25K——
2026-07-29Mottola FrankBuy1.65K——
2026-07-29Bhatt Padmanabh P.Buy2.50K——
2026-07-29Rubin JonathanBuy750——
2026-03-18Bhatt Padmanabh P.Buy7.25K$39.40285.65K
2026-03-18Bhatt Padmanabh P.Sell6.84K$49.55338.82K
2026-03-18Bhatt Padmanabh P.Sell412$50.4820.80K
2026-03-18Bhatt Padmanabh P.Sell7.25K$39.40285.65K
2026-03-17Bhatt Padmanabh P.Buy15.00K$38.60579.00K
2026-03-17Bhatt Padmanabh P.Buy12.25K$36.75450.19K
2026-03-17Bhatt Padmanabh P.Buy22.75K$39.40896.35K
2026-03-17Bhatt Padmanabh P.Sell27.71K$49.951.38M
2026-03-17Bhatt Padmanabh P.Sell22.29K$50.731.13M
2026-03-17Bhatt Padmanabh P.Sell22.75K$39.40896.35K
2026-03-17Bhatt Padmanabh P.Sell15.00K$38.60579.00K
2026-03-17Bhatt Padmanabh P.Sell12.25K$36.75450.19K
2026-03-16Bhatt Padmanabh P.Buy5.00K$27.94139.70K
2026-03-16Bhatt Padmanabh P.Buy18.00K$32.20579.60K
2026-03-16Bhatt Padmanabh P.Buy4.25K$29.61125.84K
2026-03-16Bhatt Padmanabh P.Buy22.75K$36.75836.06K
2026-03-16Bhatt Padmanabh P.Sell34.11K$50.181.71M
2026-03-16Bhatt Padmanabh P.Sell15.89K$50.49802.08K
2026-03-16Bhatt Padmanabh P.Sell5.00K$27.94139.70K
2026-03-16Bhatt Padmanabh P.Sell22.75K$36.75836.06K
2026-03-16Bhatt Padmanabh P.Sell18.00K$32.20579.60K
2026-03-16Bhatt Padmanabh P.Sell4.25K$29.61125.84K
2026-03-13Khattar Jack A.Buy12.50K——
2026-03-13Khattar Jack A.Sell12.50K——
2026-03-13Khattar Jack A.Sell24.14K$50.091.21M
2026-03-13Khattar Jack A.Sell10.74K$51.00547.84K
2026-03-13Khattar Jack A.Sell120$51.756.21K
2026-03-12Hudson Frederick M.Sell5.37K$50.61271.73K
2026-03-10Horich William ToddSell4.44K$55.00244.15K
2026-03-09Mottola FrankSell1.62K$53.6587.07K
2026-03-09Horich William ToddSell4.44K$54.00239.65K
2026-03-06Khattar Jack A.Buy38.64K——
2026-03-06Khattar Jack A.Sell16.57K$54.73907.10K
2026-03-06Khattar Jack A.Sell38.64K——
2026-03-06Mottola FrankBuy3.75K——
2026-03-06Mottola FrankSell1.79K$54.7398.13K
2026-03-06Mottola FrankSell3.75K——
2026-03-06DEC TIMOTHY CBuy3.00K——
2026-03-06DEC TIMOTHY CSell1.45K$54.7379.36K
2026-03-06DEC TIMOTHY CBuy3.00K——
2026-03-06DEC TIMOTHY CSell1.43K$54.7378.43K
2026-03-06DEC TIMOTHY CSell3.00K——
2026-03-06Horich William ToddBuy3.75K——
2026-03-06Horich William ToddBuy1.12K——
2026-03-06Horich William ToddSell521$54.7328.51K
2026-03-06Horich William ToddSell1.72K$54.7394.03K
2026-03-06Horich William ToddBuy2.62K——
2026-03-06Horich William ToddSell1.22K$54.7366.55K
2026-03-06Horich William ToddSell1.12K——
2026-03-06GEMAYEL GEORGESBuy7.91K$25.30200.00K
2026-03-06GEMAYEL GEORGESSell8.79K$53.00465.71K
2026-03-06GEMAYEL GEORGESSell7.91K$25.30200.00K
2026-03-05GEMAYEL GEORGESSell10.00K$53.71537.10K
2026-03-01Horich William ToddOther0——
2026-03-01Horich William ToddOther13.00K$39.40512.20K
2026-03-01Horich William ToddOther14.00K$36.75514.50K
2026-03-01Horich William ToddOther17.00K$29.61503.37K
2026-03-01Horich William ToddOther18.00K$32.20579.60K
2026-03-01Horich William ToddOther20.00K$38.60772.00K
2026-03-01Horich William ToddOther25.00K$27.94698.50K
2026-03-01Horich William ToddOther20.00K$33.52670.40K
2026-03-01Horich William ToddOther13.50K$50.20677.70K
2026-03-01Horich William ToddOther3.00K——
2026-03-01Horich William ToddOther2.62K——
2026-02-28Khattar Jack A.Buy38.64K——
2026-02-28DEC TIMOTHY CBuy3.00K——
2026-02-28Mottola FrankBuy3.75K——
2026-02-25Mottola FrankBuy1.88K——
2026-02-25Mottola FrankSell977$50.6949.52K
2026-02-25Mottola FrankSell1.88K——
2026-02-25DEC TIMOTHY CBuy2.50K——
2026-02-25DEC TIMOTHY CSell1.28K$50.6964.83K
2026-02-25DEC TIMOTHY CSell2.50K——
2026-02-25Bhatt Padmanabh P.Buy1.25K——
2026-02-25Bhatt Padmanabh P.Sell650$50.6932.95K
2026-02-25Bhatt Padmanabh P.Sell1.25K——
2026-02-25Rubin JonathanBuy1.25K——
2026-02-25Rubin JonathanSell675$50.6934.22K
2026-02-25Rubin JonathanSell1.25K——
2026-02-24DEC TIMOTHY CSell3.00K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 340, holders +5 vs prior quarter. Ownership 105.03%.

HolderSharesChangeChange %Value
BLACKROCK, INC.9.35M552.79K+6.28%434.87M
MILLENNIUM MANAGEMENT LLC3.85M537.24K+16.20%179.21M
VANGUARD PORTFOLIO MANAGEMENT LLC3.31M66.74K+2.06%153.74M
ARMISTICE CAPITAL, LLC2.65M750.85K+39.62%123.07M
VANGUARD CAPITAL MANAGEMENT LLC2.52M49.51K+2.01%117.05M
STATE STREET CORP2.46M171.70K+7.50%114.41M
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.2.38M341.13K+16.74%110.62M
DIMENSIONAL FUND ADVISORS LP2.08M-228.94K-9.92%96.65M
GEODE CAPITAL MANAGEMENT, LLC1.57M-53.43K-3.29%73.04M
STEPHENS INVESTMENT MANAGEMENT GROUP LLC1.49M134.49K+9.95%69.11M
RENAISSANCE TECHNOLOGIES LLC1.48M-227.04K-13.31%68.75M
LOOMIS SAYLES & CO L P1.48M49.41K+3.47%68.61M
CITADEL ADVISORS LLC1.37M-119.46K-8.00%63.90M
TWO SIGMA INVESTMENTS, LP1.18M913.15K+336.67%55.09M
GW&K INVESTMENT MANAGEMENT, LLC1.04M-17.94K-1.70%48.24M
SOFINNOVA INVESTMENTS, INC.1.04M82.02K+8.59%48.20M
QUBE RESEARCH & TECHNOLOGIES LTD922.17K423.97K+85.10%42.89M
MORGAN STANLEY876.84K-37.05K-4.05%40.78M
GOLDMAN SACHS GROUP INC819.43K-37.05K-4.33%38.11M
D. E. SHAW & CO., INC.767.67K145.22K+23.33%35.70M
NORTHERN TRUST CORP733.37K33.92K+4.85%34.11M
WOODLINE PARTNERS LP708.28K259.28K+57.75%32.94M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.703.55K703.55KNew32.72M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC703.55K-2.42K-0.34%32.72M
BANK OF AMERICA CORP /DE/621.10K-93.12K-13.04%28.89M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Supernus Pharmaceuticals (SUPN) Stock Insights

SUPN$41.08+0.12 +0.29%

$2.39B

Market Cap

-21.18

P/E

17.22

Forward P/E

—

Score

Price History